Obesity Clinical Trial
— NOURISH HEARTSOfficial title:
NOURISH HEARTS: Nutrition Outreach and Understanding: Research In Serving Hearts Through Healthy Eating And Tailored Support
Verified date | June 2024 |
Source | The Cleveland Clinic |
Contact | Narissa McCarty |
Phone | 2167801931 |
mccartn3[@]ccf.org | |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is a human-centered, three-arm, parallel-group, randomized control, implementation trial (n=75) to compare MTM (Medically Tailored Meals) only (14 meals delivered weekly for 10 weeks) vs. MTM + SMA (Shared Medical Appointments; once weekly sessions for 10 weeks) vs. a wait-list control group (MTM-Later) in patients with hypertension, type 2 diabetes, obesity, and/or metabolic syndrome. All intervention components will be culturally congruent (e.g., MTMs will include food that converges with culturally relevant diets and SMAs will be delivered by individuals with racial concordance to the target community). Primary outcomes will be implementation (recruitment and retention rates) and feasibility (engagement and satisfaction). Participants will be recruited from Cleveland Clinic's South Pointe Hospital in Warrensville Heights, a predominantly Black community with low socioeconomic status and high cardiovascular disease morbidity.
Status | Not yet recruiting |
Enrollment | 75 |
Est. completion date | December 19, 2025 |
Est. primary completion date | December 19, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Self-identification as Black or African American 2. Ability to speak and read English 3. Age = 18 years old 4. Diagnosis of any of the following: a) Hypertension (>130/80), and ever treated for hypertension; b) Type 2 Diabetes Mellitus (HgbA1c = 8%); c) Metabolic Syndrome; d) Obesity (BMI = 30) 5. Access to a web-enabled device (phone, tablet, computer) 6. Received care at Cleveland Clinic South Pointe Hospital within the past 6 months Exclusion Criteria: 1. Pre-hypertension 2. Stage C and D heart failure 3. Advanced valvular heart disease 4. Advanced heart failure class D defined as heart failure symptoms impairing daily quality of life and/or resulting in recurrent hospitalizations (>1) per previous 12 months 5. Insulin requiring type II diabetes mellitus 6. Type I diabetes mellitus 7. Advanced chronic kidney disease (= Stage 4) 8. Severe obesity (Grade III or above) as defined by BMI > 40 kg/m2 9. Patients who are in another study or nutritional support program supplying meals 10. Advanced co-morbidity with diminished life expectancy < 2 years 11. Co-morbidity requiring immunosuppressive, immunotherapy, chemotherapy, chronic antibiotic therapy 12. Inability to participate in the demands and requirements of the trial 13. Significant cognitive impairment |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Amanda Shallcross | American Heart Association |
ASA24 Dietary Assessment Tool- EGRP/DCCPS/NCI/NIH. Accessed October 23, 2023. https://epi.grants.cancer.gov/asa24/
Attkisson CC, Zwick R. The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann. 1982;5(3):233-7. doi: 10.1016/0149-7189(82)90074-x. — View Citation
Belak L, Owens C, Smith M, Calloway E, Samnadda L, Egwuogu H, Schmidt S. The impact of medically tailored meals and nutrition therapy on biometric and dietary outcomes among food-insecure patients with congestive heart failure: a matched cohort study. BMC Nutr. 2022 Oct 3;8(1):108. doi: 10.1186/s40795-022-00602-y. — View Citation
Benjamins MR, Silva A, Saiyed NS, De Maio FG. Comparison of All-Cause Mortality Rates and Inequities Between Black and White Populations Across the 30 Most Populous US Cities. JAMA Netw Open. 2021 Jan 4;4(1):e2032086. doi: 10.1001/jamanetworkopen.2020.32086. — View Citation
Berkowitz SA, Delahanty LM, Terranova J, Steiner B, Ruazol MP, Singh R, Shahid NN, Wexler DJ. Medically Tailored Meal Delivery for Diabetes Patients with Food Insecurity: a Randomized Cross-over Trial. J Gen Intern Med. 2019 Mar;34(3):396-404. doi: 10.1007/s11606-018-4716-z. Epub 2018 Nov 12. — View Citation
Berkowitz SA, Shahid NN, Terranova J, Steiner B, Ruazol MP, Singh R, Delahanty LM, Wexler DJ. "I was able to eat what I am supposed to eat"-- patient reflections on a medically-tailored meal intervention: a qualitative analysis. BMC Endocr Disord. 2020 Jan 20;20(1):10. doi: 10.1186/s12902-020-0491-z. — View Citation
Bharmal N, Beidelschies M, Alejandro-Rodriguez M, Alejandro K, Guo N, Jones T, Bradley E. A nutrition and lifestyle-focused shared medical appointment in a resource-challenged community setting: a mixed-methods study. BMC Public Health. 2022 Mar 7;22(1):447. doi: 10.1186/s12889-022-12833-6. — View Citation
Black/African American Health-Office of Minority Health. Accessed October 24, 2023. https://minorityhealth.hhs.gov/blackafrican-american-health
Blumberg SJ, Bialostosky K, Hamilton WL, Briefel RR. The effectiveness of a short form of the Household Food Security Scale. Am J Public Health. 1999 Aug;89(8):1231-4. doi: 10.2105/ajph.89.8.1231. — View Citation
Chen, G., Gully, S.M., & Eden, D. (2001). Validation of a new general self-efficacy scale. Organizational Research Methods, 4(1), 62-83
Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available. — View Citation
Cohen, S., Memelstein, R., Kamarck, T., & Hoberman, H. (1985). Measuring the functional components of social support. In I.G. Sarason & B. Sarason (Eds.), Social support: Theory, research and application (pp.73-94). The Hague: Martinus Nijhoff
Diamond JJ. Development of a reliable and construct valid measure of nutritional literacy in adults. Nutr J. 2007 Feb 14;6:5. doi: 10.1186/1475-2891-6-5. — View Citation
Eisenhauer E. In poor health: Supermarket redlining and urban nutrition. GeoJournal. 2001;53(2):125-133. doi:10.1023/A:1015772503007
FastStats- Leading Causes of Death. Centers for Disease Control and Prevention. Published January 18, 2023. Accessed October 24, 2023. https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm
Feng YS, Kohlmann T, Janssen MF, Buchholz I. Psychometric properties of the EQ-5D-5L: a systematic review of the literature. Qual Life Res. 2021 Mar;30(3):647-673. doi: 10.1007/s11136-020-02688-y. Epub 2020 Dec 7. — View Citation
Fernander AF, Duran RE, Saab PG, Llabre MM, Schneiderman N. Assessing the reliability and validity of the John Henry Active Coping Scale in an urban sample of African Americans and white Americans. Ethn Health. 2003 May;8(2):147-61. doi: 10.1080/13557850303563. — View Citation
Gaglio B, Henton M, Barbeau A, Evans E, Hickam D, Newhouse R, Zickmund S. Methodological standards for qualitative and mixed methods patient centered outcomes research. BMJ. 2020 Dec 23;371:m4435. doi: 10.1136/bmj.m4435. — View Citation
Gardiner P, McGonigal L, Villa A, Kovell LC, Rohela P, Cauley A, Rinker D, Olendzki B. Our Whole Lives for Hypertension and Cardiac Risk Factors-Combining a Teaching Kitchen Group Visit With a Web-Based Platform: Feasibility Trial. JMIR Form Res. 2022 May 16;6(5):e29227. doi: 10.2196/29227. — View Citation
Hager K, Cudhea FP, Wong JB, Berkowitz SA, Downer S, Lauren BN, Mozaffarian D. Association of National Expansion of Insurance Coverage of Medically Tailored Meals With Estimated Hospitalizations and Health Care Expenditures in the US. JAMA Netw Open. 2022 Oct 3;5(10):e2236898. doi: 10.1001/jamanetworkopen.2022.36898. — View Citation
Hays RD, Spritzer KL, Schalet BD, Cella D. PROMIS(R)-29 v2.0 profile physical and mental health summary scores. Qual Life Res. 2018 Jul;27(7):1885-1891. doi: 10.1007/s11136-018-1842-3. Epub 2018 Mar 22. — View Citation
Lara-Breitinger KM, Medina Inojosa JR, Li Z, Kunzova S, Lerman A, Kopecky SL, Lopez-Jimenez F. Validation of a Brief Dietary Questionnaire for Use in Clinical Practice: Mini-EAT (Eating Assessment Tool). J Am Heart Assoc. 2023 Jan 3;12(1):e025064. doi: 10.1161/JAHA.121.025064. Epub 2022 Dec 30. — View Citation
Lichtenstein AH, Appel LJ, Vadiveloo M, Hu FB, Kris-Etherton PM, Rebholz CM, Sacks FM, Thorndike AN, Van Horn L, Wylie-Rosett J. 2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association. Circulation. 2021 Dec 7;144(23):e472-e487. doi: 10.1161/CIR.0000000000001031. Epub 2021 Nov 2. — View Citation
Medication History for Ambulatory-Surescripts. Accessed October 23, 2023. https://surescripts.com/what-we-do/medication-history-for-ambulatory
Moore C, Coates E, Watson A, de Heer R, McLeod A, Prudhomme A. "It's Important to Work with People that Look Like Me": Black Patients' Preferences for Patient-Provider Race Concordance. J Racial Ethn Health Disparities. 2023 Oct;10(5):2552-2564. doi: 10.1007/s40615-022-01435-y. Epub 2022 Nov 7. Erratum In: J Racial Ethn Health Disparities. 2023 Oct;10(5):2614. doi: 10.1007/s40615-022-01489-y. — View Citation
Prescription Prices, Coupons & Pharmacy Information. GoodRx. Accessed October 23, 2023. https://www.goodrx.com/
Research methods: Is restricted randomisation necessary? Accessed June 1, 2021. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1482349/
Rohela P, Olendzki B, McGonigal LJ, Villa A, Gardiner P. A Teaching Kitchen Medical Groups Visit with an eHealth Platform for Hypertension and Cardiac Risk Factors: A Qualitative Feasibility Study. J Altern Complement Med. 2021 Nov;27(11):974-983. doi: 10.1089/acm.2021.0148. Epub 2021 Aug 5. — View Citation
Satia JA. Diet-related disparities: understanding the problem and accelerating solutions. J Am Diet Assoc. 2009 Apr;109(4):610-5. doi: 10.1016/j.jada.2008.12.019. No abstract available. — View Citation
Sim J, Lewis M. The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency. J Clin Epidemiol. 2012 Mar;65(3):301-8. doi: 10.1016/j.jclinepi.2011.07.011. Epub 2011 Dec 9. — View Citation
Winham DM. Culturally tailored foods and CVD prevention. Am J Lifestyle Med. 2009;3(1):64S-68S. doi: 10.1177/1559827609335552. — View Citation
Woodward EN, Matthieu MM, Uchendu US, Rogal S, Kirchner JE. The health equity implementation framework: proposal and preliminary study of hepatitis C virus treatment. Implement Sci. 2019 Mar 12;14(1):26. doi: 10.1186/s13012-019-0861-y. — View Citation
* Note: There are 32 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Qualitative characterization of participants' lived experiences and engagement | 4 focus groups (n=5 in each group, 2 groups from each treatment arm - MTM and MTM + SMA) will be conducted to understand barriers and facilitators to engaging in each of the active treatments. | Week 10 | |
Primary | Recruitment Rate | Recruitment is a measure of treatment implementation. Recruitment rate will be measured by # of participants enrolled in study/# passed eligibility screening. | Baseline through Week 10 | |
Primary | Retention Rate | Retention is a measure of treatment implementation. Retention rate will be measured by # of completed assessments at week 10/# randomized to treatment arm. | Baseline through Week 10 | |
Primary | SMA Attendance | Engagement will be assessed by Shared Medical Appointment (SMA) session attendance over the 10 week period. | Baseline through Week 10 | |
Primary | MTMs Consumed | Engagement will be assessed by proportion of Medically Tailored Meals (MTMs) consumed. | Baseline through Week 10 | |
Primary | Satisfaction of the Intervention | Satisfaction of MTM vs. MTM + SMA will be assessed using the Net Promoter Score (scale of 0 to 10; 9-10 being promoters, 7-8 being passives, and 0-6 being detractors) | Baseline through Week 10 | |
Secondary | Eating Behavior | Changes in eating behavior will be measured using the Mini-EAT (Eating Assessment Tool) and Fast Food/Restaurant Frequency Questionnaires. | Baseline and Week 10 | |
Secondary | Body Weight | Body weight will be measured in pounds. | Baseline and Week 10 | |
Secondary | Waist/Hip Circumference | Waist/Hip circumference will be expressed as a ratio. | Baseline and Week 10 | |
Secondary | Systolic and Diastolic Blood Pressure (mmHg) | Systolic and diastolic blood pressure will be measured and expressed as mmHg. | Baseline and Week 10 | |
Secondary | Hemoglobin A1c (HbA1c, mmol/mol) | Hemoglobin A1c will be evaluated through peripheral blood draw to assess diabetes control. | Baseline and Week 10 | |
Secondary | Trimethylamine N-oxide (TMAO, uM) | Trimethylamine N-oxide will be evaluated through peripheral blood draw to assess cardiovascular disease risk. | Baseline and Week 10 | |
Secondary | Uric Acid (mg/dL) | Uric Acid will be evaluated through peripheral blood draw to assess cardiovascular disease and diabetes risk. | Baseline and Week 10 | |
Secondary | Vitamin D 25 Hydroxy (ng/mL) | Vitamin D 25 Hydroxy will be evaluated through peripheral blood draw to asses for Vitamin D deficiency. | Baseline and Week 10 | |
Secondary | High Sensitivity C-Reactive Protein (hsCRP, mg/dL) | High Sensitivity C-Reactive Protein will be evaluated through peripheral blood draw to assess inflammation. | Baseline and Week 10 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |